≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Motor disorders

DOID Endpoint Browser

KRA_PSY_MOTOR

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F82
  • Hospital discharge: ICD-9 — 3154A
  • Cause of death: ICD-10 — F82
  • Cause of death: ICD-9 — 3154A

2 out of 7 registries used, show all original rules.

612

4. Check minimum number of events

None

612

5. Include endpoints

None

612

6. Filter based on genotype QC (FinnGen only)

612

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F80-F89
Name in latin
Perturbatio specifica progressus functionis motoricae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 612 255 357
Unadjusted period prevalence (%) 0.13 0.09 0.16
Median age at first event (years) 6.12 6.05 6.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
552
Matched controls
5511
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F82
ICD-10 Finland
Specific developmental disorder of motor function
10964.6
323.0
517
7
F83
ICD-10 Finland
Mixed specific developmental disorders
11.1
71.2
145
171
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.9
56.6
142
232
R62.0
ICD-10 Finland
Delayed milestone
8.6
56.2
132
194
F80.1
ICD-10 Finland
Expressive language disorder
11.6
53.5
104
108
XA800
NOMESCO Finland
Neuropsychological investigation
6.4
51.3
151
305
Z3226
NOMESCO Finland
Physiotherapist
4.3
50.3
243
847
R4120
NOMESCO Finland
Occupational therapy
7.9
47.1
116
180
Z2445
NOMESCO Finland
Psychologist
5.0
46.3
176
475
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
8.0
41.6
100
148
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
39.0
37
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
38.2
164
488
R4110
NOMESCO Finland
Physiotherapy
3.6
37.0
218
849
F80.2
ICD-10 Finland
Receptive language disorder
9.7
34.8
73
85
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
31.5
235
1061
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.3
31.1
128
358
Z2221
NOMESCO Finland
Medical doctor
3.1
30.6
221
969
Z3231
NOMESCO Finland
Registered nurse
2.9
30.1
281
1458
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.4
29.6
177
675
Z2446
NOMESCO Finland
Social worker
3.4
28.9
172
653
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
12.1
28.2
52
47
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
27.4
173
680
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
7.6
26.6
64
93
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
26.5
258
1339
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.7
24.4
88
212
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
24.3
146
548
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
22.5
114
374
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
22.4
104
317
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
22.3
194
920
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
21.9
153
633
602
Kela drug reimbursment
Children's severe malnutrition
6.2
21.5
60
107
RT160
NOMESCO Finland
NA
10.0
20.4
41
44
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.5
20.4
76
189
ZXE00
NOMESCO Finland
One hour or less
2.3
19.7
266
1569
RT150
NOMESCO Finland
NA
7.2
19.5
48
72
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.6
19.2
69
165
RL140
NOMESCO Finland
NA
8.1
19.0
43
57
R1260
NOMESCO Finland
Evaluation of communicative skills
10.1
18.6
37
39
Z50.5
ICD-10 Finland
Speech therapy
4.0
18.6
79
222
P07.2
ICD-10 Finland
Extreme immaturity
22.6
18.3
26
12
ZY010
NOMESCO Finland
Hospital outpatient
3.1
18.1
110
408
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
18.0
100
348
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
18.0
108
396
N05AH03
ATC
olanzapine; systemic
4.4
17.7
66
164
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.4
17.4
65
161
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
17.3
86
275
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.4
16.5
62
155
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.3
16.4
90
309
N05AX08
ATC
risperidone; systemic
3.9
16.2
70
199
N06BA04
ATC
methylphenidate; oral
3.4
16.1
84
278
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
8.1
16.1
36
47
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
22.8
15.6
22
10
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
7.4
15.6
37
53
RF120
NOMESCO Finland
NA
12.8
15.5
27
22
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
15.2
117
502
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
8.0
15.1
34
45
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.4
14.9
77
253
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
14.8
127
576
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.8
14.5
63
180
F81.0
ICD-10 Finland
Specific reading disorder
7.1
14.4
35
52
RL130
NOMESCO Finland
NA
6.5
14.3
37
60
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
12.4
14.2
25
21
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
14.0
87
324
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
13.9
82
294
N05AH04
ATC
quetiapine; oral
2.6
13.9
114
504
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.6
13.9
65
198
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.8
13.8
93
366
N03AG01
ATC
valproic acid; systemic, rectal
3.8
13.7
59
167
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
8.7
13.7
29
35
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
13.3
132
645
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
13.0
173
968
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.9
13.0
32
49
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
6.5
12.9
33
53
R1250
NOMESCO Finland
Evaluation of functional capability
7.5
12.9
30
42
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.8
12.7
54
152
R4130
NOMESCO Finland
Speech therapy
4.5
12.6
45
107
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
12.4
189
1114
N05AX12
ATC
aripiprazole; systemic
3.6
12.3
57
172
ZXA00
NOMESCO Finland
Right side
2.6
12.2
99
432
H52.2
ICD-10 Finland
Astigmatism
4.3
12.2
45
111
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
12.1
109
505
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.4
11.9
43
104
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
8.9
11.6
24
28
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
10.3
11.6
22
22
R5599
NOMESCO Finland
Other rehabilitation service
4.7
11.6
39
88
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
11.5
57
182
RS222
NOMESCO Finland
NA
5.7
11.3
32
59
H50.0
ICD-10 Finland
Convergent concomitant strabismus
6.0
11.2
30
52
RF420
NOMESCO Finland
NA
13.2
10.7
18
14
Z31.5
ICD-10 Finland
Genetic counselling
2.9
10.7
67
252
H01AC01
ATC
somatropin; parenteral
3.9
10.6
44
121
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.5
10.6
24
33
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
111.9
10.4
11
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.3
10.1
37
91
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
10.1
125
667
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
11.6
10.1
18
16
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
10.1
52
171
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
10.0
63
238
ZXD20
NOMESCO Finland
Day surgery
2.7
9.7
70
283
H50.30
ICD-10 Finland
Intermittent esotropy
5.2
9.7
29
58
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.5
9.6
24
38
N05CD08
ATC
midazolam; nasal, systemic
3.9
9.5
38
102
L02AE02
ATC
leuprorelin; implant, parenteral
7.7
9.5
21
28
RD210
NOMESCO Finland
NA
2.9
9.4
58
214
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.5
9.4
73
311
H35.1
ICD-10 Finland
Retinopathy of prematurity
17.9
9.4
14
8
RT422
NOMESCO Finland
NA
30.6
9.4
12
*
SPAT1229
SPAT
Assessment of need for aid
6.2
9.3
24
40
ZXA05
NOMESCO Finland
Left side
2.4
9.3
84
386
H50.31
ICD-10 Finland
Intermittent exotropia
4.5
9.2
32
75
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
9.2
100
504
FM2CE
NOMESCO Finland
NA
2.6
9.2
68
282
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
15.9
9.1
14
9
N03AX14
ATC
levetiracetam; systemic
3.8
9.0
37
102
XX4AW
NOMESCO Finland
NA
3.7
8.9
38
108
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
10.9
8.8
16
15
K03.66
ICD-10 Finland
Tooth plaque
2.1
8.8
101
520
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
8.8
35
94
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.5
8.7
30
70
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
8.7
52
190
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
8.7
85
406
WX882
NOMESCO Finland
High dependency care
2.3
8.6
80
374
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.5
8.5
24
45
N03AX09
ATC
lamotrigine; oral
3.2
8.4
43
142
ZXD05
NOMESCO Finland
Urgent procedure
1.9
8.3
141
846
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
8.2
75
345
RS211
NOMESCO Finland
NA
5.3
8.2
24
47
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
14.7
8.2
13
9
C03CA01
ATC
furosemide; systemic
3.6
8.1
35
101
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.0
8.1
31
81
RF210
NOMESCO Finland
NA
5.7
8.1
22
40
WX730
NOMESCO Finland
Conventional respirator
5.8
7.9
21
37
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
8.6
7.8
16
19
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.1
7.8
18
26
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.1
7.8
41
138
E22.80
ICD-10 Finland
Central precocious puberty
15.3
7.7
12
8
N05AH02
ATC
clozapine; systemic
4.5
7.7
26
60
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.5
7.7
26
60
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
4.3
7.7
27
65
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
4.6
7.6
25
56
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.0
7.6
44
157
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
25.4
7.6
10
*
183
Kela drug reimbursment
Lamotrigin and topiramate
4.9
7.5
23
48
RS220
NOMESCO Finland
NA
3.9
7.5
29
77
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
7.4
47
178
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
13.6
7.4
12
9
BF20A
NOMESCO Finland
NA
13.6
7.4
12
9
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
7.4
52
211
WX002
NOMESCO Finland
Sedation and analgesia
2.3
7.4
68
317
R5140
NOMESCO Finland
Monitoring the use of the aid
4.3
7.4
26
63
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
7.4
77
381
N29
ICPC
Neurological sympt/complt other
8.5
7.4
15
18
N05AA02
ATC
levomepromazine; systemic
4.6
7.3
24
54
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
11.0
7.3
13
12
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
7.3
90
476
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
7.2
61
270
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
7.2
230
1665
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.8
7.2
46
176
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.1
7.2
21
42
R27.0
ICD-10 Finland
Ataxia, unspecified
30.4
7.2
9
*
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
20.3
7.1
10
5
G91.1
ICD-10 Finland
Obstructive hydrocephalus
12.2
7.1
12
10
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
7.1
181
1227
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.8
7.1
22
47
RT130
NOMESCO Finland
NA
10.2
7.1
13
13
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.9
7.1
27
71
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
7.0
63
290
F84.5
ICD-10 Finland
Asperger syndrome
4.3
7.0
24
57
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
6.5
7.0
17
27
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.4
6.9
55
239
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
6.8
6.8
16
24
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
6.8
47
188
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
6.8
53
226
RF430
NOMESCO Finland
NA
16.9
6.8
10
6
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
6.7
33
107
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.1
6.7
24
60
E34.31
ICD-10 Finland
Short stature, prenatal disorder
6.0
6.6
17
29
R11
ICD-10 Finland
Nausea and vomiting
2.1
6.6
70
349
WX722
NOMESCO Finland
PEEP
3.3
6.6
31
97
A28
ICPC
Limited function/disability NOS
2.5
6.6
50
212
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
8.8
6.6
13
15
N28
ICPC
Limited function/disability (N)
8.8
6.6
13
15
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
6.6
32
103
C03DA01
ATC
spironolactone; oral
3.7
6.6
27
76
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.9
6.6
38
137
RS120
NOMESCO Finland
NA
7.0
6.5
15
22
XCK00
NOMESCO Finland
Perimetry
4.6
6.5
21
47
H52.0
ICD-10 Finland
Hypermetropia
2.9
6.5
38
138
H50.1
ICD-10 Finland
Divergent concomitant strabismus
5.8
6.5
17
30
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.4
6.4
29
88
RT121
NOMESCO Finland
NA
70.5
6.4
7
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
70.5
6.4
7
*
ZXA10
NOMESCO Finland
Bilateral
1.9
6.4
102
595
31
HP
Congenital heart failure surgery
14.5
6.4
10
7
ZX108
NOMESCO Finland
Inhalation
5.0
6.4
19
39
RT490
NOMESCO Finland
NA
5.3
6.4
18
35
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.3
108
645
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
9.4
6.3
12
13
K07.24
ICD-10 Finland
Open bite
3.0
6.3
34
118
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.4
6.3
51
224
RS231
NOMESCO Finland
NA
18.2
6.3
9
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
6.3
47
197
WX704
NOMESCO Finland
Intubation
2.9
6.3
36
129
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
6.3
6
*
AA1AD
NOMESCO Finland
CT of head and brain
2.4
6.2
50
218
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
6.2
130
830
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.0
6.2
35
123
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
7.8
6.1
13
17
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
6.1
101
599
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
10.2
6.0
11
11
G47.3
ICD-10 Finland
Sleep apnoea
2.6
6.0
40
158
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.9
6.0
35
127

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
329
2044
2.31
22.56
15.4
11.8
mmol/l
1.2
1.2
1.04
309
1877
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
318
1956
2.29
22.23
17.4
12.7
mmol/l
1.2
1.2
1.53
309
1856
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
377
2535
2.26
20.64
7.2
6.0
u/l
124.2
116.9
0.87
358
2386
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
277
1703
2.13
18.33
4.7
3.4
nmol/l
68.6
67.1
0.42
264
1614
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
29
48
6.27
16.92
14.6
16.4
nmol/l
18725.7
640.9
0.49
29
48
(3014111) Lactate [Moles/volume] in Serum or Plasma
104
440
2.63
16.25
14.2
14.5
mmol/l
1.3
1.5
0.54
95
398
(3024561) Albumin [Mass/volume] in Serum or Plasma
223
1359
2.00
14.26
9.3
8.4
g/l
37.9
38.2
0.33
211
1300
(40758558) Short blood count panel - Blood
251
1613
1.93
13.60
9.5
9.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
241
1539
1.92
13.22
8.7
7.9
umol/l
21.3
18.7
0.39
226
1423
(3018418) pH of Serum or Plasma
154
842
2.10
13.11
4.4
4.4
ph
7.4
7.4
1.36
16
140
(3019550) Sodium [Moles/volume] in Serum or Plasma
507
4160
2.25
13.04
20.4
11.8
mmol/l
139.6
139.4
1.30
496
4027
(3052851) Hemolysis interference index of Serum or Plasma
48
150
3.38
12.79
2.5
3.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
506
4163
2.22
12.69
20.2
11.9
mmol/l
4.0
3.9
0.95
494
4006
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
1012
2.00
12.43
3.1
3.0
mmol/l
2.4
2.4
1.49
160
922
(3003458) Phosphate [Moles/volume] in Serum or Plasma
162
929
2.00
11.99
13.6
11.6
mmol/l
1.3
1.3
0.17
154
889
(3049233) Organic acids panel - Urine
19
32
6.07
10.87
1.1
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
376
2869
1.79
10.84
11.3
10.2
e9/l
0.2
0.2
0.22
341
2433
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
427
3385
1.85
10.83
4.5
3.4
pmol/l
14.6
14.5
0.54
396
3102
(3000991) Gas panel - Venous blood
157
922
1.94
10.70
14.8
11.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
367
2793
1.77
10.54
10.0
9.3
e9/l
0.0
0.0
0.07
325
2332
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
147
855
1.94
10.26
1.8
1.4
pmol/l
98.5
99.6
0.10
70
441
(3001604) Monocytes [#/volume] in Blood
365
2794
1.75
10.07
10.0
9.3
e9/l
0.6
0.6
0.77
323
2333
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
467
3857
1.87
9.79
4.9
3.7
mu/l
2.0
1.9
0.86
442
3640
(3003396) Base excess in Arterial blood by calculation
61
254
2.55
9.72
19.6
15.8
mmol/l
-0.4
-0.1
0.15
49
207
(3013826) Glucose [Moles/volume] in Serum or Plasma
320
2376
1.72
9.72
10.7
7.4
mmol/l
5.9
6.1
1.38
304
2190
(3013650) Neutrophils [#/volume] in Blood by Automated count
390
3058
1.75
9.72
14.3
11.3
e9/l
3.6
3.6
0.25
344
2563
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
200
1303
1.79
9.67
4.8
4.7
u/l
40.8
34.5
0.47
195
1245
(3044889) 12 lead EKG panel
261
1835
1.73
9.66
2.9
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
164
1008
1.85
9.59
8.6
10.0
mmol/l
0.8
1.2
0.92
133
793
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
524
4519
2.08
9.36
11.7
8.5
u/l
32.8
27.8
1.78
511
4367
(3012095) Magnesium [Moles/volume] in Serum or Plasma
114
627
2.00
9.29
15.4
13.2
mmol/l
0.8
0.8
0.17
108
600
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
141
834
1.89
9.27
4.1
3.8
e6/l
4.5
2.0
1.77
86
487
(3019150) Specific gravity of Urine by Refractometry
150
908
1.86
9.16
3.2
3.0
kg/l
1.0
1.0
0.03
27
145
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
103
549
2.05
9.14
5.6
7.5
umol/l
6.0
6.8
0.25
89
455
(3013336) Amino acids [Identifier] in Serum or Plasma
22
50
4.51
9.10
3.4
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
333
2538
1.67
8.86
4.5
3.2
mmol/mol
36.5
36.4
0.10
322
2421
(42870588) Differential panel, method unspecified - Blood
290
2146
1.66
8.54
9.3
9.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
369
2910
1.66
8.42
10.1
9.1
e9/l
2.3
2.3
0.08
336
2498
(3009214) Lutropin [Units/volume] in Serum or Plasma
81
407
2.13
8.38
2.8
2.1
u/l
4.6
5.8
1.20
60
258
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
366
2902
1.64
7.98
3.8
2.3
mmol/l
5.7
5.4
3.16
343
2673
(3045414) Leukocytes [Presence] in Urine
40
151
2.75
7.75
1.8
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
170
1124
1.70
7.51
4.2
4.7
mmol/l
7.9
8.9
1.14
150
1046
(3011397) Hemoglobin [Presence] in Urine by Test strip
160
1049
1.70
7.26
3.7
3.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
26
5.47
7.24
2.1
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
88
481
1.96
7.23
1.4
1.3
nmol/l
20.2
19.1
0.31
81
426
(3022096) Basophils/100 leukocytes in Blood
337
2658
1.59
7.19
10.4
9.5
%
0.6
0.6
0.95
324
2557
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
821
1.75
6.96
4.2
3.7
e6/l
0.5
0.6
0.31
75
468
(3006504) Eosinophils/100 leukocytes in Blood
342
2719
1.57
6.96
10.4
9.4
%
3.1
3.2
0.64
329
2603
(3017446) Testosterone [Moles/volume] in Serum or Plasma
79
423
1.99
6.87
2.6
2.1
nmol/l
9.5
11.5
0.85
65
347
(3044640) Blood type and Crossmatch panel - Blood
173
1173
1.65
6.86
3.6
3.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
69
352
2.07
6.85
2.9
2.1
iu/l
6.0
6.4
0.17
51
221
(3022948) Iron [Moles/volume] in Serum or Plasma
104
619
1.81
6.56
3.8
3.0
umol/l
12.9
14.1
0.94
95
601
(3019069) Monocytes/100 leukocytes in Blood
342
2743
1.55
6.51
11.0
9.5
%
8.3
8.4
0.30
330
2636
(3004789) Transferrin [Mass/volume] in Serum or Plasma
97
567
1.84
6.48
3.8
3.0
g/l
2.6
2.6
0.08
86
547
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
403
1.97
6.46
14.1
6.6
ng/l
868.1
1362.4
0.53
58
330
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
29
4.90
6.45
2.2
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
211
1523
1.58
6.41
5.8
4.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
351
2841
1.54
6.34
3.6
2.5
mmol/l
1.3
1.2
2.93
335
2712
(3030981) Hyaline casts [#/volume] in Urine by Automated count
38
156
2.52
6.27
2.6
4.1
e6/l
0.1
0.3
0.66
38
150
(3022313) Gas panel - Capillary blood
134
869
1.69
6.24
15.6
8.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
370
3038
1.54
6.20
3.9
2.7
mmol/l
4.3
4.4
1.72
354
2905
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
146
978
1.64
5.98
3.4
3.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
347
2824
1.52
5.95
10.2
9.0
%
51.1
49.9
0.93
335
2724
(3002385) Erythrocyte distribution width [Ratio]
515
4602
1.73
5.73
22.9
14.7
%
13.3
13.1
4.65
507
4525
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
144
971
1.62
5.72
17.2
8.7
kpa
5.0
5.0
0.25
139
936
(3002030) Lymphocytes/100 leukocytes in Blood
350
2873
1.50
5.62
10.5
9.1
%
34.0
34.9
0.75
338
2768
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
143
968
1.62
5.58
17.2
8.6
mmol/l
0.4
1.0
1.43
106
692
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
364
3018
1.50
5.52
3.8
2.6
mmol/l
2.7
2.7
0.30
350
2851
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
114
732
1.68
5.47
6.4
4.9
mg/l
1.2
1.9
0.99
85
496
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
336
2751
1.48
5.36
8.9
6.5
ml/min/173m2
113.8
110.4
1.99
229
1912
(1175426) CD3 cells/100 lymphocytes in Blood
33
137
2.48
5.35
3.3
3.7
%
65.1
66.5
0.13
33
137
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
137
2.48
5.35
3.3
3.7
%
11.1
10.1
0.22
28
127
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
529
1.77
5.34
4.2
3.1
%
19.7
22.6
1.39
83
507
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
89
538
1.76
5.30
5.1
3.4
ng/l
759.9
1287.6
0.70
56
284
(3019060) Gas panel - Arterial blood
23
80
2.94
5.21
6.5
9.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
768
1.64
5.14
1.8
1.8
mmol/l
1.6
1.3
1.69
108
703
(3014007) Fractional oxyhemoglobin in Arterial blood
40
185
2.24
5.11
26.2
17.8
%
92.4
95.6
0.72
40
185
(3026008) Bacteria identified in Urine by Culture
132
895
1.60
5.08
3.1
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
195
1444
1.51
5.06
5.6
4.3
e6/l
11.0
42.7
3.93
153
1108
(3018677) aPTT in Platelet poor plasma by Coagulation assay
108
699
1.66
5.01
9.1
7.5
s
31.0
31.1
0.07
108
691
(3018095) Leukocytes [#/volume] in Urine
223
1700
1.48
5.01
6.7
5.0
e6/l
34.2
51.9
0.54
161
1148
(3011412) CD3 cells [#/volume] in Blood
33
142
2.39
4.97
3.4
3.7
e9/l
1.7
1.4
0.51
23
95
(3007853) Bacteria identified in Skin by Aerobe culture
100
636
1.68
4.95
2.1
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
358
3000
1.46
4.86
3.7
2.6
mmol/l
1.2
1.4
9.03
345
2850
(3035637) Corticotropin [Mass/volume] in Plasma
42
205
2.12
4.72
1.8
1.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
39
186
2.16
4.64
26.8
17.7
%
0.6
0.7
1.40
39
186
(3004119) Hemoglobin [Mass/volume] in Venous blood
45
227
2.05
4.64
5.4
14.1
g/l
132.4
128.9
0.46
45
222
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
160
2.25
4.61
26.7
19.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
111
743
1.60
4.48
4.4
4.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
31
137
2.32
4.42
3.2
3.6
e6/l
657.8
483.7
0.76
24
97
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
31
138
2.30
4.35
3.2
3.6
e9/l
0.3
0.2
0.68
24
99
(3021589) Normoblasts [#/volume] in Blood
320
2665
1.41
4.26
10.2
10.8
e9/l
0.0
0.0
0.46
255
2043
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
133
2.31
4.26
3.4
3.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
146
2.25
4.25
14.7
11.7
mmol/l
22.3
23.2
1.03
32
132
(3005322) IgE [Units/volume] in Serum or Plasma
84
536
1.65
4.10
1.5
1.4
u/ml
227.9
427.2
0.92
78
510
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
10
8.06
4.06
1.8
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
525
4820
1.60
4.02
13.4
7.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
211
1647
1.42
4.00
5.4
4.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
126
891
1.52
3.97
16.9
8.5
kpa
9.7
9.9
0.39
120
861
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
399
1.73
3.94
2.4
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
213
1.98
3.93
4.7
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
133
954
1.50
3.91
4.6
3.2
mosm/kgh2o
597.3
603.6
0.09
120
837
(3015736) pH of Urine
201
1563
1.42
3.87
3.8
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
177
1346
1.44
3.85
5.7
4.1
e6/l
0.2
0.2
0.29
132
1019
(4034850)
19
71
2.72
3.83
14.4
4.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
28
127
2.25
3.79
3.4
3.7
%
20.9
25.1
1.14
28
127
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
102
2.40
3.76
26.0
27.0
u/ml
0.3
0.3
0.16
15
66
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
99
673
1.56
3.73
2.2
1.7
%
1.7
1.4
0.60
92
617
(3027273) Bicarbonate [Moles/volume] in Venous blood
31
148
2.15
3.72
5.1
8.1
mmol/l
24.2
24.3
0.08
31
140
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
398
1.70
3.71
2.7
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
128
922
1.48
3.68
9.2
3.9
inr
1.1
1.1
0.02
25
274
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
477
5115
0.68
3.65
3.7
3.9
—
—
—
0
0
(3019225) pH of Specimen
34
171
2.04
3.58
4.7
4.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
80
2.54
3.55
2.9
4.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
70
443
1.65
3.54
2.1
2.0
g/l
1.0
0.9
0.45
65
421
(3031040) Bacteria [#/volume] in Urine by Automated count
303
2554
1.36
3.49
5.4
3.8
e6/l
163.4
185.1
—
10
23
(36304419) Bacteria [Presence] in Urine
176
1358
1.41
3.49
5.7
4.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
238
0.33
3.38
1.5
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
14
5.75
3.34
1.8
2.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
183
1.96
3.33
1.7
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
89
2.40
3.33
2.1
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
584
5565
2.00
3.30
25.0
15.3
e9/l
266.9
266.0
0.11
567
5321
(3006245) CD3-CD19+ cells/100 cells in Blood
29
142
2.09
3.29
3.6
4.0
%
21.8
17.1
0.55
29
142
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
188
2311
0.73
3.26
2.0
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
72
2.54
3.21
2.9
4.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
503
0.49
3.21
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
33
3.36
3.18
1.2
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
34
179
1.95
3.18
2.4
4.7
mg/l
274.4
407.5
1.48
34
174
(3026361) Erythrocytes [#/volume] in Blood
584
5575
1.96
3.12
24.9
15.2
e12/l
4.7
4.7
1.04
563
5319
(3035941) MCH [Entitic mass]
584
5575
1.96
3.12
24.9
15.1
pg
29.0
29.1
0.82
578
5503
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
60
379
1.64
3.07
2.1
2.7
u/l
23.0
31.3
2.43
49
320
(3010813) Leukocytes [#/volume] in Blood
584
5578
1.95
3.07
25.0
15.2
e9/l
7.0
6.9
0.42
564
5327
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
26
126
2.10
3.04
1.7
1.5
ug/l
5.8
7.5
0.30
26
118
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
223
0.35
2.98
1.4
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
85
589
1.51
2.94
7.2
7.2
%
1.5
1.4
0.42
79
567
(3024731) MCV [Entitic volume]
583
5574
1.89
2.92
24.9
15.1
fl
86.3
86.4
0.28
577
5502
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
108
2.17
2.91
2.5
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
46
2.86
2.91
5.2
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
61
393
1.61
2.90
1.5
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
128
964
1.41
2.87
4.5
3.4
e6/l
6.9
6.4
0.14
113
851
(3022229) Phosphate [Moles/volume] in Urine
19
83
2.32
2.84
2.6
3.4
mmol/l
21.6
19.7
0.18
19
78
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
96
2.22
2.84
2.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
180
1.87
2.81
3.2
3.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
18
4.47
2.79
1.4
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
23
3.94
2.77
1.3
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
27
138
1.99
2.77
3.4
3.7
e6/l
525.0
334.3
0.76
20
91
(3037467) Urinalysis macro (dipstick) panel - Urine
320
2780
1.31
2.76
5.6
4.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
233
1939
1.32
2.74
4.0
3.3
estimate
0.0
0.0
0.00
20
352
(3022621) pH of Urine by Test strip
34
189
1.84
2.73
2.1
2.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
175
1.87
2.71
2.6
4.8
e6/l
35.9
196.1
1.56
26
123
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
175
1.87
2.71
2.5
4.8
e6/l
9.3
5.4
0.21
24
120
(3045424) Erythrocytes [Presence] in Urine
14
54
2.62
2.70
1.4
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
111
1443
0.71
2.62
1.8
1.8
—
—
—
0
0
(44790047)
25
127
2.00
2.61
3.2
2.3
—
—
—
0
0
(44790049)
25
127
2.00
2.61
3.2
2.3
—
—
—
0
0
(44790048)
25
127
2.00
2.61
3.2
2.3
—
—
—
0
0
(44806118)
25
127
2.00
2.61
3.2
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
31
170
1.86
2.61
2.3
4.7
mmol/l
3.3
3.3
0.35
31
163
(4010399)
38
223
1.74
2.57
1.3
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
297
2571
1.29
2.56
5.0
4.0
u/l
35.5
28.3
1.55
290
2468
(3019309) Folate [Moles/volume] in Red Blood Cells
42
254
1.70
2.56
1.5
1.6
nmol/l
990.6
1097.9
0.33
32
204
(3019832) Treponema pallidum Ab [Presence] in Serum
78
1075
0.68
2.56
2.1
1.9
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
5
7
7.17
2.54
1.0
1.0
—
—
—
0
0
(4268621)
12
44
2.75
2.54
2.7
2.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
541
1.48
2.50
2.6
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
166
1.84
2.47
3.9
2.2
—
—
—
0
0
(4306422)
15
63
2.41
2.46
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
52
337
1.59
2.44
2.7
2.7
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
13
51
2.57
2.44
2.2
1.7
nmol/l
20.8
19.8
—
5
16
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
511
4781
1.39
2.42
15.9
10.6
mg/l
22.5
22.5
0.00
388
3259
(3000330) Specific gravity of Urine by Test strip
25
131
1.94
2.42
2.6
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
230
1938
1.29
2.40
5.7
4.8
estimate
0.0
0.0
0.00
25
380
(21494814) CD8 cells/100 lymphocytes in Specimen
6
12
5.02
2.40
2.7
3.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
6
12
5.02
2.40
2.7
3.2
%
9.2
6.5
—
6
12
(3020891) Body temperature
19
90
2.14
2.39
6.7
8.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
40
2.77
2.37
8.4
9.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
52
341
1.57
2.33
2.4
2.1
mmol/l
2.4
2.4
0.01
40
290
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
155
1.84
2.31
2.1
3.1
ml/min/173m2
85.2
93.4
—
7
45
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
106
2.01
2.26
1.5
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
122
950
1.35
2.22
3.7
3.5
estimate
0.0
0.0
0.50
25
362
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
90
667
1.40
2.22
3.1
2.1
ng/l
74.5
35.6
0.53
45
240
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
48
313
1.57
2.21
2.3
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
9
5.57
2.21
1.0
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
188
1.73
2.19
1.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
122
1.91
2.17
2.7
2.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
19
94
2.05
2.16
4.0
4.3
umol/l
23.9
25.0
0.23
19
94
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
115
1.94
2.16
3.2
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
250
0.43
2.16
1.5
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
229
1951
1.27
2.14
4.1
3.4
estimate
0.0
0.0
0.00
25
370
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
30
3.02
2.14
3.1
5.8
ug/l
167.6
205.3
—
9
30
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
161
1.77
2.07
3.5
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
60
418
1.48
2.06
4.6
5.1
e9/l
73.6
62.1
1.15
47
256
(3013512) EKG study
73
529
1.43
2.05
3.0
2.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
76
2.13
2.02
3.1
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
403
1.48
2.02
1.6
1.3
iu/ml
137.8
130.9
0.04
12
134
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
26
3.09
2.01
3.4
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
381
0.56
1.96
1.1
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
267
1.57
1.92
5.9
8.6
g/l
0.2
0.4
1.12
26
219
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
20
106
1.91
1.91
5.7
6.1
ug/l
2.6
1.9
0.53
20
106
(4198724)
19
99
1.94
1.90
2.7
2.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
138
1667
0.77
1.90
2.4
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
276
1.55
1.90
2.0
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
121
1.84
1.89
5.0
19.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
32
197
1.65
1.88
3.8
3.0
mu/l
14.5
22.3
1.09
32
189
(3011288) Drugs identified in Urine by Screen method
68
495
1.42
1.87
2.5
2.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
19
100
1.92
1.85
2.9
1.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
46
2.41
1.84
2.5
5.1
ug/l
18.2
24.5
1.28
11
46
(3010503) CD19 cells [#/volume] in Blood
6
17
3.54
1.83
3.2
3.3
e9/l
0.2
0.1
—
6
17
(4146454)
5
12
4.18
1.82
2.6
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
307
0.54
1.77
1.7
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
241
1.56
1.75
1.5
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
36
2.51
1.73
1.0
1.1
mg/l
262.9
313.1
—
9
31
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
9
36
2.51
1.73
1.4
1.1
%
72.7
75.6
—
9
36
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
9
36
2.51
1.73
1.4
1.1
mu/l
651.3
375.7
—
9
36
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
36
2.51
1.73
27.1
7.1
mmol/l
1.2
1.2
—
9
30
(40761536) Microorganisms panel - Urine sediment
19
329
0.56
1.71
6.8
3.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
13
3.85
1.71
4.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
48
2.31
1.70
2.2
1.8
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
11
48
2.31
1.70
6.4
7.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
11
48
2.31
1.70
5.5
7.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
111
1.82
1.69
1.5
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
80
1022
0.75
1.66
1.8
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
31
2.59
1.65
1.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
17
90
1.91
1.65
3.9
2.6
mmol/l
1.5
2.0
—
10
75
(3032641) Amino acids panel - Urine
7
25
2.81
1.64
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
25
2.81
1.64
2.0
2.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
69
2.05
1.64
1.6
1.3
u/ml
9.0
3.7
—
8
32
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
515
0.66
1.63
1.4
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
50
2.21
1.56
3.1
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
324
2939
1.21
1.56
5.1
4.2
mm/h
8.1
7.0
1.00
307
2728
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
14
71
1.99
1.53
17.2
10.4
mg/l
9.6
9.1
0.10
14
65
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
138
1148
1.26
1.53
3.8
3.1
mg/l
2.8
2.6
0.48
126
1015
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
33
2.43
1.53
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
33
2.43
1.53
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
115
1.76
1.52
1.4
1.4
ug/g
328.1
396.8
1.01
15
60
(1616796) Gas panel - Central venous blood
17
93
1.85
1.51
4.8
6.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
21
2.86
1.50
2.3
2.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
51
2.17
1.50
1.5
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
510
4855
1.28
1.49
23.8
13.9
g/l
335.3
335.9
0.63
504
4810
(3012516) Albumin [Mass/volume] in Urine
58
429
1.38
1.49
3.6
3.9
mg/l
1179.3
167.2
0.43
44
339
(3020682) Albumin/Creatinine [Ratio] in Urine
58
429
1.38
1.49
3.8
4.7
mg/mmol
4.9
15.3
1.54
40
341
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
58
2.08
1.49
1.5
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
65
2.01
1.48
4.5
5.9
—
—
—
0
0
(4035726)
32
211
1.54
1.47
2.4
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
28
2.51
1.45
4.6
2.2
umol/l
13.0
18.3
—
7
28
(3010375) cycloSPORINE [Mass/volume] in Blood
15
80
1.89
1.44
39.7
35.4
ug/l
140.9
149.5
0.15
15
75
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
59
2.05
1.43
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
95
1.81
1.43
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
110
1.74
1.43
2.7
2.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
110
1.74
1.43
2.8
4.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
165
1.60
1.41
2.8
5.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
81
1.87
1.40
2.5
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
486
0.68
1.39
1.5
1.5
—
—
—
0
0
(4027681)
10
46
2.19
1.39
1.1
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
14
74
1.91
1.38
62.7
44.6
ug/l
6.7
6.6
0.14
14
67
(40768797) Stomach Pathology biopsy report
45
323
1.42
1.38
1.6
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
52
383
1.39
1.38
9.2
7.4
u/l
252.3
296.5
1.11
52
376
(4094501)
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
214
1889
1.20
1.33
1.9
1.7
g/l
1.7
1.7
0.02
112
992
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
136
1.63
1.32
2.2
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
155
1327
1.22
1.32
3.4
3.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
34
2.36
1.29
2.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
278
0.60
1.29
1.1
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
18
2.78
1.28
1.4
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
48
2.09
1.27
1.2
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
35
2.29
1.27
2.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
92
1.75
1.25
7.1
9.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
117
981
1.23
1.22
1.9
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
56
1.98
1.21
1.5
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
73
579
1.29
1.21
2.5
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
64
1.89
1.17
1.1
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
135
1556
0.83
1.17
2.7
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
244
2200
1.18
1.16
3.9
3.2
ug/l
65.0
59.3
0.29
236
2084
(40760892) CBC W Ordered Manual Differential panel - Blood
115
969
1.22
1.15
5.7
5.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
72
1.82
1.14
3.1
3.5
%
17.5
18.3
—
7
44
(3017181) Myelocytes/100 leukocytes in Blood
39
285
1.39
1.12
7.6
5.8
%
0.8
0.6
0.22
13
89
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
58
1.91
1.11
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
43
321
1.36
1.09
1.2
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
21
2.38
1.09
1.2
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
169
1.49
1.07
1.5
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
59
1.87
1.07
9.6
9.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
187
1.46
1.04
1.4
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
9
46
1.96
1.03
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
189
0.57
1.03
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
138
1.53
1.03
3.1
5.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
34
2.06
1.02
5.3
4.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
106
0.47
1.02
4.6
3.9
e9/l
2.4
3.1
—
5
106
(3003740) Influenza virus B Ag [Presence] in Specimen
11
188
0.58
1.02
1.4
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
83
1.70
1.01
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
223
1.41
0.99
3.2
1.9
%
30.3
31.7
0.26
21
167
(3019230) Fractional oxyhemoglobin in Venous blood
18
116
1.56
0.96
5.7
20.2
%
77.7
72.6
0.67
18
116
(3009542) Hematocrit [Volume Fraction] of Blood
524
5062
1.22
0.96
22.6
13.6
%
40.1
40.1
0.09
460
4538
(3029634) Reagin Ab [Titer] in Serum by VDRL
20
133
1.52
0.94
1.6
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
128
1451
0.85
0.92
2.4
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
55
1.83
0.91
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
10
55
1.83
0.91
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
28
2.15
0.91
2.2
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
206
0.62
0.91
1.0
1.1
—
8.5
—
0
27
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
29
2.07
0.89
1.2
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
42
1.91
0.88
3.4
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
103
1.56
0.87
3.6
2.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
30
2.00
0.87
1.0
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
64
1.73
0.85
3.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
113
0.52
0.83
1.7
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
171
1.41
0.83
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
171
1.41
0.83
1.4
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
81
1.61
0.81
8.1
7.8
mmol/l
1.5
2.1
—
6
45
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
645
0.80
0.80
2.5
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
33
1.82
0.79
5.8
4.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
347
0.74
0.78
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.8
2.0
—
—
—
0
0
(4062490)
14
90
1.56
0.77
1.6
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
14
90
1.56
0.77
1.4
1.7
pmol/l
125.4
207.9
1.43
14
90
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
288
1.30
0.76
2.6
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
107
1.50
0.76
2.4
2.0
iu/l
2.4
6.4
—
6
39
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
99
1.52
0.75
1.7
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
253
0.70
0.74
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
24
2.08
0.74
1.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
173
1567
1.14
0.74
1.6
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
263
1.31
0.73
5.3
5.0
%
0.7
0.4
—
10
64
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
107
0.55
0.73
7.7
4.2
%
42.8
49.5
—
6
107
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
374
0.76
0.71
1.2
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
26
1.92
0.70
1.0
2.1
g/l
0.0
0.0
—
5
26
(3022670) pH of Venous cord blood
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
26
1.92
0.70
1.0
2.1
g/l
0.0
0.0
—
5
26
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
126
1.44
0.70
1.0
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
27
1.85
0.68
1.0
2.1
g/l
40.5
41.2
—
5
27
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
155
0.64
0.67
1.7
1.7
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
7
43
1.63
0.66
1.1
5.3
—
124.0
—
0
22
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
29
1.72
0.63
1.0
2.1
g/l
0.0
0.2
—
5
29
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
29
1.72
0.63
1.0
2.1
g/l
0.0
0.0
—
5
29
(3041672) Baker's yeast Ab [Presence] in Serum
5
29
1.72
0.63
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
29
1.72
0.63
1.0
1.0
miu/ml
2497.4
1786.6
—
5
29
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
217
1.30
0.61
2.4
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(4211845)
0
21
0.00
0.60
0.0
2.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
34
272
1.26
0.59
1.1
1.2
—
31.0
—
0
8
(3011985) Renin [Units/volume] in Plasma
8
52
1.54
0.59
1.8
1.7
mu/l
44.3
284.7
—
8
47
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
106
1.42
0.57
3.1
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
283
1.25
0.56
2.8
2.2
—
88.0
—
0
24
(3021440) Promyelocytes/100 leukocytes in Blood
34
274
1.25
0.56
7.8
5.9
%
0.1
0.0
0.16
12
83
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
358
0.80
0.53
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
461
1.18
0.53
2.7
2.6
u/l
7591.8
4250.1
0.24
13
168
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
234
0.76
0.50
3.2
2.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
47
1.49
0.47
1.3
1.7
mmol/l
8.4
6.6
—
7
29
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
102
1.38
0.47
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
83
0.60
0.46
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
32
265
1.21
0.44
8.1
5.9
%
0.0
0.0
0.74
11
73
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
183
0.76
0.42
1.9
1.5
iu/ml
0.0
0.1
—
7
44
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
35
295
1.19
0.41
1.9
2.2
—
15.3
—
0
22
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
33
1.51
0.41
2.8
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
33
1.51
0.41
1.6
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
16
0.00
0.41
0.0
3.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
17
0.00
0.40
0.0
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
55
484
1.15
0.39
2.8
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
61
1.31
0.39
3.6
2.4
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
56
495
1.14
0.38
1.5
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
124
1.29
0.38
2.8
2.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
36
1.39
0.38
2.4
3.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
80
1.38
0.38
3.1
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
490
0.87
0.37
1.2
1.2
iu/ml
13.8
15.2
—
8
105
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
69
1.30
0.37
1.1
1.2
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
21
170
1.24
0.36
1.0
1.0
mu/l
10.2
9.4
0.21
15
139
(3007566) Smooth muscle Ab [Titer] in Serum
19
152
1.25
0.36
1.4
1.9
—
61.1
—
0
18
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
72
1.39
0.36
1.4
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
78
0.64
0.36
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
235
1.20
0.35
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
79
0.63
0.35
9.0
2.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
124
0.72
0.35
1.0
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
124
0.72
0.35
1.7
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
43
1.39
0.35
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
43
1.39
0.35
1.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
854
1.10
0.34
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
44
1.36
0.34
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
44
1.36
0.34
1.0
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
211
2007
1.07
0.34
1.5
1.8
u/ml
0.4
3.4
5.88
39
361
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
855
1.10
0.34
1.7
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
208
0.81
0.32
1.1
1.1
—
—
—
0
0
(44813793)
11
83
1.33
0.31
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
54
1.30
0.30
2.1
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
18
147
1.23
0.30
1.3
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
55
1.27
0.30
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
14
111
1.26
0.29
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
162
0.80
0.29
1.6
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
205
0.82
0.29
2.1
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
468
0.89
0.28
1.2
1.2
u/ml
0.9
5.4
2.07
14
146
(3004809) Band form neutrophils/100 leukocytes in Blood
8
63
1.27
0.27
6.0
4.6
%
1.0
0.9
—
8
51
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
67
1.19
0.26
1.3
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
113
1.24
0.26
3.6
4.7
u/ml
3.8
16.4
0.91
14
106
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
158
0.82
0.24
1.6
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
81
0.74
0.24
1.0
1.2
—
1.6
—
0
6
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
82
0.73
0.24
1.2
1.4
—
290.0
—
0
5
(3016879) Cocaine [Presence] in Urine
76
706
1.08
0.24
2.5
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
124
1.21
0.23
1.8
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
38
1.31
0.23
1.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
38
1.31
0.23
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
38
1.31
0.23
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
95
0.73
0.22
1.0
1.2
—
28.0
—
0
12
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
95
0.73
0.22
1.0
1.2
—
2.2
—
0
9
(3003327) Ova and parasites identified in Stool by Light microscopy
28
314
0.88
0.22
1.7
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
266
1.13
0.22
1.4
1.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
1.4
—
0
10
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
10.3
—
0
11
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
103
0.77
0.21
1.3
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
104
0.76
0.21
1.1
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.4
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
258
1.13
0.20
1.4
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
89
1.24
0.20
6.7
23.9
%
14.0
12.0
1.25
11
89
(3041096) Erythrocytes [Presence] in Urine by Automated
95
996
0.94
0.19
3.5
2.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
153
0.84
0.18
1.6
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
58
1.21
0.18
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
205
0.87
0.18
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
65
609
1.07
0.17
1.4
1.5
titre
980.0
550.1
—
8
93
(3050129) First trimester maternal screen panel - Serum or Plasma
29
319
0.90
0.17
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
262
1.11
0.17
1.5
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
182
0.87
0.16
1.4
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
234
0.89
0.16
1.0
1.1
u/ml
0.9
0.6
—
9
116
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
12
140
0.85
0.16
1.2
1.4
u/ml
52.4
17.8
—
7
118
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
79
0.75
0.15
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
41
438
0.93
0.14
1.1
1.2
u/ml
4.6
6.7
0.44
27
336
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
112
1.16
0.14
1.5
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
8
99
0.80
0.13
1.0
1.2
—
44.0
—
0
6
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
1226
0.96
0.13
1.9
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
431
1.07
0.13
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
79
756
1.05
0.12
2.5
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
178
0.89
0.12
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
78
747
1.05
0.11
2.5
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
423
0.94
0.11
1.1
1.2
u/ml
3.9
4.2
0.05
14
144
(3028300) Cannabinoids [Presence] in Urine
79
758
1.04
0.11
2.5
2.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
19
172
1.10
0.11
1.2
1.5
u/ml
2.0
4.3
0.76
13
122
(3008401) Mugwort IgE Ab [Units/volume] in Serum
41
432
0.94
0.10
1.1
1.2
u/ml
1.7
1.3
0.15
27
316
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
105
1.14
0.10
3.3
4.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
99
1017
0.96
0.10
3.3
3.3
ug/g
88.9
122.9
0.86
78
818
(3000764) Benzodiazepines [Presence] in Urine
78
750
1.04
0.10
2.5
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
96
1.14
0.10
1.9
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
236
0.93
0.09
1.5
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
56
1.07
0.08
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
360
1.06
0.08
2.7
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
233
1.07
0.08
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
771
0.97
0.08
2.1
2.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
6
72
0.83
0.07
1.3
1.9
mmol/l
8.3
7.2
—
6
45
(40765089) Chromosome analysis panel - Blood by G-banded
8
73
1.09
0.07
1.3
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
67
647
1.04
0.07
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
98
1.12
0.07
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
176
1.08
0.07
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
128
1.09
0.06
5.2
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
89
903
0.98
0.04
2.5
2.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
159
0.94
0.04
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
159
0.94
0.04
1.5
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
46
470
0.97
0.03
1.2
1.3
u/ml
3.4
2.5
0.18
28
316
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
37
358
1.03
0.03
2.8
2.0
u/ml
165.2
177.8
0.10
20
176
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
168
0.95
0.03
1.3
1.5
u/ml
24.7
10.7
0.24
11
118
(3006184) Hemoglobin [Mass/volume] in Capillary blood
11
102
1.08
0.02
2.7
3.0
g/l
134.2
137.8
0.25
11
85
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
107
0.93
0.02
1.3
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
241
1.04
0.02
1.1
1.1
u/ml
4.1
10.0
0.99
12
153
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
137
0.94
0.02
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
271
1.03
0.02
1.4
1.3
miu/ml
330.1
263.8
0.32
11
133
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
203
1.03
0.01
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
203
1.03
0.01
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
203
1.03
0.01
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
203
1.03
0.01
1.5
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
265
0.98
0.00
1.2
1.1
u/ml
3.7
8.9
1.36
14
155
(3000492) Spirometry study
38
373
1.02
0.00
1.7
1.4
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
13
132
0.98
0.00
1.0
1.0
kpa
3.5
3.3
—
7
105
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
164
1.03
0.00
1.5
1.6
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
13
135
0.96
0.00
1.0
1.0
kpa
6.7
7.4
—
7
108
(3006598) pH of Arterial cord blood
13
135
0.96
0.00
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
158
1.01
0.00
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
61
606
1.00
0.00
1.2
1.3
—
181.8
—
0
25
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.4
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.8
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.9
—
2.7
—
0
9
(3045142) Bone marrow Pathology biopsy report
6
67
0.89
0.00
1.5
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
64
0.93
0.00
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
64
0.93
0.00
14.5
9.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
221.6
—
0
7
(40768441) Liver Pathology biopsy report
6
60
1.00
0.00
1.3
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
53
0.94
0.00
3.2
2.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
37.0
—
0
5
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
1256.2
—
0
5
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
83.0
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
3.4
—
12.4
—
0
5
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
126.8
—
0
5
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
53
0.94
0.00
1.0
1.0
g/l
175.6
160.7
—
5
53
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
20.6
—
0
5
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
1.4
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_MOTOR – Motor disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).